February 04, 2025

Predicting Response to KRAS G12C Inhibitors in NSCLC

Investigators discovered that measuring the interaction between the RAS and RAF proteins could provide valuable insights into the effectiveness of treatments in patients with KRAS G12C–mutated NSCLC.

The ASCO Post

February 04, 2025

FDA Approves Clinical Trials for Genetically Modified Pig Kidney Transplants

FDA-cleared clinical trials will assess the safety, immunogenicity, and viability of genetically modified pig kidney transplants in patients with end-stage renal disease.

Conexiant

February 04, 2025

FDA Approves First Companion Diagnostic to Identify Patients With Metastatic Breast Cancer Eligible for T-DXd

The FDA has approved a label expansion for the PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody to identify patients with HR-positive, HER2-ultralow metastatic breast cancer who may be e...

The ASCO Post

February 04, 2025

FDA Approves New Drug-Device Combo for Parkinson’s Symptoms

The U.S. Food and Drug Administration has approved Onapgo, a continuous apomorphine hydrochloride infusion, for the treatment of motor fluctuations in adult patients with advanced Parkinson’s disease.

Conexiant

February 04, 2025

Can R-CHOP–Like Therapy Effectively Treat Late-Relapse DLBCL?

Late relapse of diffuse large B-cell lymphoma (DLBCL) may represent a new lymphoma arising from a common precursor cell that is essentially chemotherapy-naive. Treatment with curative intent using a s...

The ASCO Post

February 04, 2025

Toxic Metals, Glyphosate Found in Girl Scout Cookies

Lab tests found glyphosate in all sampled Girl Scout cookies and toxic metals in a majority, sparking health and safety concerns.

Conexiant

February 04, 2025

Rising Advanced Prostate Cancer Rates in California Follow Changes to Recommendations

The incidence of advanced prostate cancer rose and the mortality rate plateaued in most regions across the state of California following a USPSTF recommendation to cease routinely screening all men fo...

The ASCO Post

February 04, 2025

Bicistronic CAR T-Cell Therapy Demonstrates Clinical Activity in Relapsed or Refractory B-Cell ALL

A novel bicistronic CD19/CD22-directed CAR T-cell therapy (B019) has demonstrated high remission rates, durable responses, and a favorable safety profile among children with relapsed or refractory B-c...

The ASCO Post

February 04, 2025

Health Agencies Face Lawsuit Over Data Removal

A medical advocacy group sues U.S. health agencies over the removal of public health data in response to an executive order targeting 'gender ideology extremism.' The lawsuit seeks to reinstate the removed webpages and challenges an OPM memorandum, naming the CDC, FDA, and HHS as defendants.

Reuters